Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 979105, 8 pages
http://dx.doi.org/10.1155/2012/979105
Review Article

The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages

Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea

Received 22 September 2012; Revised 3 November 2012; Accepted 7 November 2012

Academic Editor: Sunil Kumar Manna

Copyright © 2012 Tao Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ferrero-Miliani, O. H. Nielsen, P. S. Andersen, and S. E. Girardin, “Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 227–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Eiro and F. J. Vizoso, “Inflammation and cancer,” World Journal of Gastrointestinal Surgery, vol. 4, no. 3, pp. 62–72, 2012. View at Google Scholar
  3. F. M. Moret, V. Badot, B. R. Lauwerys, and J. A. van Roon, “Intraarticular soluble interleukin-17 receptor levels are increased in patients with rheumatoid arthritis and correlate with local mediators of inflammation: comment on the article by Pickens et al,” Arthritis and Rheumatism, vol. 64, no. 2, pp. 594–595, 2012. View at Google Scholar
  4. W. L. Yong, P. H. Kim, W. H. Lee, and A. A. Hirani, “Interleukin-4, oxidative stress, vascular inflammation and atherosclerosis,” Biomolecules and Therapeutics, vol. 18, no. 2, pp. 135–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Wyss-Coray and J. Rogers, “Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, Article ID a006346, 2012. View at Google Scholar
  6. Y. G. Lee, J. Lee, S. E. Byeon et al., “Functional role of Akt in macrophage-mediated innate immunity,” Frontiers in Bioscience, vol. 16, no. 2, pp. 517–530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. G. Barin, N. R. Rose, and D. Čiháková, “Macrophage diversity in cardiac inflammation: a review,” Immunobiology, vol. 217, no. 5, pp. 468–475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Qureshi, S. N. Vogel, C. Van Way III, C. J. Papasian, A. A. Qureshi, and D. C. Morison, “The proteasome: a central regulator of inflammation and macrophage function,” Immunologic Research, vol. 31, no. 3, pp. 243–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. Butchar, K. V. L. Parsa, C. B. Marsh, and S. Tridandapani, “Negative regulators of Toll-like receptor 4-mediated macrophage inflammatory response,” Current Pharmaceutical Design, vol. 12, no. 32, pp. 4143–4153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Batbayar, D. H. Lee, and H. W. Kim, “Immunomodulation of fungal β-glucan in host defense signaling by dectin-1,” Biomolecules & Therapeutics, vol. 20, no. 5, pp. 433–445, 2012. View at Google Scholar
  11. E. Marchlik, P. Thakker, T. Carlson et al., “Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality,” Journal of Leukocyte Biology, vol. 88, no. 6, pp. 1171–1180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. K. Perry, E. K. Chow, J. B. Goodnough, W. C. Yeh, and G. Cheng, “Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection,” The Journal of Experimental Medicine, vol. 199, no. 12, pp. 1651–1658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. X. H. Xie, N. Zang, S. M. Li et al., “Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells,” Inflammation, vol. 35, no. 4, pp. 1392–1401, 2012. View at Google Scholar
  14. T. Yu, J. Shim, Y. Yang et al., “3-(4-(tert-Octyl)phenoxy)propane-1, 2-diol suppresses inflammatory responses via inhibition of multiple kinases,” Biochemical Pharmacology, vol. 83, no. 11, pp. 1540–1551, 2012. View at Google Scholar
  15. M. C. Muñoz, J. F. Giani, M. A. Mayer, J. E. Toblli, D. Turyn, and F. P. Dominici, “TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance,” Journal of Endocrinology, vol. 201, no. 2, pp. 185–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Schmitt, M. A. Ballou, M. N. Correa, E. J. DePeters, J. K. Drackley, and J. J. Loor, “Dietary lipid during the transition period to manipulate subcutaneous adipose tissue peroxisome proliferator-activated receptor-gamma co-regulator and target gene expression,” Journal of Dairy Science, vol. 94, no. 12, pp. 5913–5925, 2011. View at Google Scholar
  17. K. Y. Chua, L. C. Kuo, and C. H. Huang, “DNA vaccines for the prevention and treatment of allergy,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 1, pp. 50–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Tojima, A. Fujimoto, M. Delhase et al., “NAK is an IκB kinase-activating kinase,” Nature, vol. 404, no. 6779, pp. 778–782, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Pomerantz and D. Baltimore, “NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase,” The EMBO Journal, vol. 18, no. 23, pp. 6694–6704, 1999. View at Google Scholar · View at Scopus
  20. D. ] Hammaker, D. L. Boyle, and G. S. Firestein, “Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis,” Rheumatology, vol. 51, no. 4, pp. 610–618, 2012. View at Google Scholar
  21. M. J. May, S. E. Larsen, J. H. Shim, L. A. Madge, and S. Ghosh, “A novel ubiquitin-like domain in IκB kinase β is required for functional activity of the kinase,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45528–45539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. R. Shen and W. C. Hahn, “Emerging roles for the non-canonical IKKs in cancer,” Oncogene, vol. 30, no. 6, pp. 631–641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Xu, Y. C. Lo, Q. Li et al., “Crystal structure of inhibitor of kappaB kinase beta,” Nature, vol. 472, no. 7343, pp. 325–330, 2011. View at Google Scholar
  24. S. Sankar, H. Chan, W. J. Romanow, J. Li, and R. J. Bates, “IKK-i signals through IRF3 and NFκB to mediate the production of inflammatory cytokines,” Cellular Signalling, vol. 18, no. 7, pp. 982–993, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Clément, S. Meloche, and M. J. Servant, “The IKK-related kinases: from innate immunity to oncogenesis,” Cell Research, vol. 18, no. 9, pp. 889–899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. I. Idris, M. Krishnan, P. Simic et al., “Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo,” The FASEB Journal, vol. 24, no. 11, pp. 4545–4555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Lee, M. Long, A. J. Adler, R. S. Mittler, and A. T. Vella, “The IKK-neutralizing compound bay 11 kills super effector CD8 T cells by altering caspase-dependent activation-induced cell death,” Journal of Leukocyte Biology, vol. 85, no. 1, pp. 175–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. C. Huang, W. S. Chen, Y. J. Chen et al., “Hepatitis B virus X protein induces IKKalpha nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1446–1454, 2012. View at Publisher · View at Google Scholar
  29. E. Park, B. Liu, X. Xia, F. Zhu, W. B. Jami, and Y. Hu, “Role of IKKα in skin squamous cell carcinomas,” Future Oncology, vol. 7, no. 1, pp. 123–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Tezil, C. Bodur, O. Kutuk, and H. Basaga, “IKK-beta mediates chemoresistance by sequestering FOXO3, a critical factor for cell survival and death,” Cellular Signalling, vol. 24, no. 6, pp. 1361–1368, 2012. View at Google Scholar
  31. J. Wei, M. Shi, W. Q. Wu et al., “IkappaB kinase-beta inhibitor attenuates hepatic fibrosis in mice,” World Journal of Gastroenterology, vol. 17, no. 47, pp. 5203–5213, 2011. View at Publisher · View at Google Scholar
  32. M. Rushe, L. Silvian, S. Bixler et al., “Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site,” Structure, vol. 16, no. 5, pp. 798–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. Shifera, “Proteins that bind to IKKγ (NEMO) and down-regulate the activation of NF-κB,” Biochemical and Biophysical Research Communications, vol. 396, no. 3, pp. 585–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Ng, B. A. Friedman, S. Schmid et al., “IkappaB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 52, pp. 21170–21175, 2011. View at Google Scholar
  35. K. A. Fitzgerald, S. M. McWhirter, K. L. Faia et al., “IKKE and TBKI are essential components of the IRF3 signalling pathway,” Nature Immunology, vol. 4, no. 5, pp. 491–496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Ogasawara, M. Sasaki, Y. Itoh et al., “Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 2, pp. 154–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. H. Kim, D. S. Yoo, S. Y. Lee et al., “The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects,” Pharmazie, vol. 66, no. 4, pp. 293–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. K. Lee, S. Y. Kim, Y. S. Kim, W. H. Lee, D. H. Hwang, and J. Y. Lee, “Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin,” Biochemical Pharmacology, vol. 77, no. 8, pp. 1391–1400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. S. Youn, J. Y. Lee, S. I. Saitoh et al., “Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea,” Biochemical Pharmacology, vol. 72, no. 7, pp. 850–859, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Chien, S. Kim, R. Bumeister et al., “RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival,” Cell, vol. 127, no. 1, pp. 157–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Soulat, T. Bürckstümmer, S. Westermayer et al., “The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response,” The EMBO Journal, vol. 27, no. 15, pp. 2135–2146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Joung, Z. Y. Park, S. Rani, O. Takeuchi, S. Akira, and J. Y. Lee, “Akt contributes to activation of the TRIF-dependent signaling pathways of TLRS by interacting with TANK-binding kinase 1,” Journal of Immunology, vol. 186, no. 1, pp. 499–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Xie, D. Zhang, B. Zhao et al., “IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 16, pp. 6474–6479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Bonnard, C. Mirtsos, S. Suzuki et al., “Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription,” The EMBO Journal, vol. 19, no. 18, pp. 4976–4985, 2000. View at Google Scholar · View at Scopus
  45. M. Hallman, M. RÄmet, and R. A. Ezekowitz, “Toll-like receptors as sensors of pathogens,” Pediatric Research, vol. 50, no. 3, pp. 315–321, 2001. View at Google Scholar · View at Scopus
  46. S. Sharma, B. R. TenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott, “Triggering the interferon antiviral response through an IKK-related pathway,” Science, vol. 300, no. 5622, pp. 1148–1151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. M. McWhirter, K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis, “IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 233–238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Mori, M. Yoneyama, T. Ito, K. Takahashi, F. Inagaki, and T. Fujita, “Identification of ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation,” The Journal of Biological Chemistry, vol. 279, no. 11, pp. 9698–9702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Caillaud, A. G. Hovanessian, D. E. Levy, and I. J. Marié, “Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7,” The Journal of Biological Chemistry, vol. 280, no. 18, pp. 17671–17677, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. T. F. Cheng, S. Brzostek, O. Ando, S. Van Scoy, K. P. Kumar, and N. C. Reich, “Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection,” Journal of Immunology, vol. 176, no. 12, pp. 7462–7470, 2006. View at Google Scholar · View at Scopus
  51. R. Lin, C. Heylbroeck, P. M. Pitha, and J. Hiscott, “Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome- mediated degradation,” Molecular and Cellular Biology, vol. 18, no. 5, pp. 2986–2996, 1998. View at Google Scholar · View at Scopus
  52. M. Sato, H. Suemori, N. Hata et al., “Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction,” Immunity, vol. 13, no. 4, pp. 539–548, 2000. View at Google Scholar · View at Scopus
  53. T. Shimada, T. Kawai, K. Takeda et al., “IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases,” International Immunology, vol. 11, no. 8, pp. 1357–1362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. H. R. Kim, S. H. Lee, and G. Jung, “The hepatitis B viral X protein activates NF-κB signaling pathway through the up-regulation of TBK1,” FEBS Letters, vol. 584, no. 3, pp. 525–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Harris, S. Olière, S. Sharma et al., “Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKKε,” Journal of Immunology, vol. 177, no. 4, pp. 2527–2535, 2006. View at Google Scholar · View at Scopus
  56. N. Fujiwara and K. Kobayashi, “Macrophages in inflammation,” Current Drug Targets, vol. 4, no. 3, pp. 281–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Yu, J. Lee, Y. G. Lee et al., “In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum,” Journal of Ethnopharmacology, vol. 128, no. 1, pp. 139–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Yu, Y. J. Lee, H. M. Yang et al., “Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE2 production is mediated by suppression of NF-κB and AP-1 activation signaling cascade,” Journal of Ethnopharmacology, vol. 134, no. 1, pp. 11–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Yu, H. M. Ahn, T. Shen et al., “Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1197–1206, 2011. View at Publisher · View at Google Scholar
  60. T. Yu, S. Lee, W. S. Yang et al., “The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 566–573, 2012. View at Publisher · View at Google Scholar
  61. H. Hemmi, O. Takeuchi, S. Sato et al., “The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection,” The Journal of Experimental Medicine, vol. 199, no. 12, pp. 1641–1650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Huang, T. Liu, L. G. Xu, D. Chen, Z. Zhai, and H. B. Shu, “SIKE is an IKKε/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways,” The EMBO Journal, vol. 24, no. 23, pp. 4018–4028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Mancuso, A. Midiri, C. Biondo et al., “Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria,” Journal of Immunology, vol. 178, no. 5, pp. 3126–3133, 2007. View at Google Scholar · View at Scopus
  64. K. E. Cole, C. A. Strick, T. J. Paradis et al., “Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non- ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3,” The Journal of Experimental Medicine, vol. 187, no. 12, pp. 2009–2021, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. C. J. Wiedermann, E. Kowald, N. Reinisch et al., “Monocyte haptotaxis induced by the RANTES chemokine,” Current Biology, vol. 3, no. 11, pp. 735–739, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Cocchi, A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso, “Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells,” Science, vol. 270, no. 5243, pp. 1811–1815, 1995. View at Google Scholar · View at Scopus
  67. E. G. McIver, J. Bryans, K. Birchall et al., “Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKepsilon kinases,” Bioorganic & Medicinal Chemistry Letters, vol. 22, pp. 7169–7173, 2012. View at Google Scholar
  68. K. Clark, L. Plater, M. Peggie, and P. Cohen, “Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IκB Kinase : a distinct upstream kinase mediates ser-172 phosphorylation and activation,” The Journal of Biological Chemistry, vol. 284, no. 21, pp. 14136–14146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Clark, M. Peggie, L. Plater et al., “Novel cross-talk within the IKK family controls innate immunity,” Biochemical Journal, vol. 434, no. 1, pp. 93–104, 2011. View at Publisher · View at Google Scholar · View at Scopus